Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.
Cancer. 2012 Jun 15;118(12):3128-34. doi: 10.1002/cncr.26510. Epub 2011 Oct 17.
Cancer. 2012.
PMID: 22006123
Free article.
Clinical Trial.
Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer.
Giaccone G, Zatloukal P, Roubec J, Floor K, Musil J, Kuta M, van Klaveren RJ, Chaudhary S, Gunther A, Shamsili S.
Giaccone G, et al. Among authors: shamsili s.
J Clin Oncol. 2009 Sep 20;27(27):4481-6. doi: 10.1200/JCO.2008.21.1862. Epub 2009 Aug 17.
J Clin Oncol. 2009.
PMID: 19687333
Clinical Trial.
Item in Clipboard
A new paraneoplastic encephalomyelitis autoantibody reactive with the axon initial segment.
Shams'ili S, de Leeuw B, Hulsenboom E, Jaarsma D, Smitt PS.
Shams'ili S, et al.
Neurosci Lett. 2009 Dec 25;467(2):169-72. doi: 10.1016/j.neulet.2009.10.031. Epub 2009 Oct 13.
Neurosci Lett. 2009.
PMID: 19833174
Item in Clipboard
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, Vecht C, Sillevis Smitt P.
Shams'ili S, et al.
Brain. 2003 Jun;126(Pt 6):1409-18. doi: 10.1093/brain/awg133.
Brain. 2003.
PMID: 12764061
Free article.
Item in Clipboard
An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.
Shams'ili S, de Beukelaar J, Gratama JW, Hooijkaas H, van den Bent M, van 't Veer M, Sillevis Smitt P.
Shams'ili S, et al.
J Neurol. 2006 Jan;253(1):16-20. doi: 10.1007/s00415-005-0882-0.
J Neurol. 2006.
PMID: 16444604
Clinical Trial.
Item in Clipboard
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.
Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, Honnorat J, Sillevis Smitt P, Graus F.
Bernal F, et al.
Neurology. 2003 Jan 28;60(2):230-4. doi: 10.1212/01.wnl.0000041495.87539.98.
Neurology. 2003.
PMID: 12552036
Clinical Trial.
Item in Clipboard
Cite
Cite